The presence of the key characteristics of DM1 (nuclear mutant mRNA aggregates, MBNL proteins sequestration, alternative splicing defects) validated the pathological relevance of this first DM1 hPSC-based model. This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.